文献速递细菌感染、耐药与抗菌药物

复发性金黄色葡萄球菌菌血症的危险因素

Risk Factors for Recurrent Staphylococcus aureus Bacteremia.
PubMed 文献 · Clin Infect Dis · 2021-01-01

研究比较了复发性金黄色葡萄球菌菌血症(R-SAB)与单次发作(S-SAB)患者的临床、细菌和宿主特征。756例患者中69例(9.1%)发生R-SAB,其中复发30例(43.5%)、再感染39例(56.5%)。黑人血液透析患者发生R-SAB的风险最高,急性期血浆RANTES水平在R-SAB中较高。

要点

  • R-SAB发生率为9.1%,复发与再感染比例相近。
  • 黑人血液透析患者R-SAB风险显著高于白人血液透析患者。
  • 急性期血浆RANTES水平升高与R-SAB相关。

核心结论

  • 本研究识别了R-SAB的多个危险因素,黑人血液透析患者风险最大。
  • R-SAB患者急性期血浆RANTES水平高于匹配的S-SAB对照,值得进一步研究。

研究设计与样本

  • 研究纳入756例SAB患者,比较R-SAB与S-SAB的临床、细菌和宿主特征。
  • 所有SAB分离株进行spa基因分型,R-SAB分离株进行PFGE,40对PFGE不可区分株进行全基因组测序。
  • R-SAB与S-SAB患者按年龄、种族、性别和细菌基因型1:1匹配,用25种分析物多重组珠阵列定量细胞因子。

主要发现

  • 756例中69例(9.1%)发生R-SAB,其中复发30例(43.5%)、再感染39例(56.5%)。
  • 年龄、种族、血液透析依赖、异物存在、耐甲氧西林金黄色葡萄球菌和持续性菌血症分别与复发可能性相关。
  • 多因素风险模型显示黑人血液透析患者发生R-SAB的比值比为9.652(95%CI 5.402-17.418),白人血液透析患者为4.53(95%CI 1.696-10.879)。
  • 全基因组测序在所有病例中证实了PFGE解读。

临床怎么用

  • 对黑人血液透析患者应加强R-SAB风险评估与监测。
  • 急性期血浆RANTES水平或可作为R-SAB风险辅助标志物,但需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To understand the clinical, bacterial, and host characteristics associated with recurrent Staphylococcus aureus bacteremia (R-SAB), patients with R-SAB were compared to contemporaneous patients with a single episode of SAB (S-SAB). METHODS: All SAB isolates underwent spa genotyping. All isolates from R-SAB patients underwent pulsed-field gel electrophoresis (PFGE). PFGE-indistinguishable pairs from 40 patients underwent whole genome sequencing (WGS). Acute phase plasma from R-SAB and S-SAB patients was matched 1:1 for age, race, sex, and bacterial genotype, and underwent cytokine quantification using 25-analyte multiplex bead array. RESULTS: R-SAB occurred in 69 (9.1%) of the 756 study patients. Of the 69 patients, 30 experienced relapse (43.5%) and 39 reinfection (56.5%). Age, race, hemodialysis dependence, presence of foreign body, methicillin-resistant Staphyloccus aureus, and persistent bacteremia were individually associated with likelihood of recurrence. Multivariate risk modeling revealed that black hemodialysis patients were nearly 2 times more likely (odds ratio [OR] = 9.652 [95% confidence interval [CI], 5.402-17.418]) than white hemodialysis patients (OR = 4.53 [95% CI, 1.696-10.879]) to experience R-SAB. WGS confirmed PFGE interpretations in all cases. Median RANTES (regulated on activation, normal T cell expressed and secreted) levels in acute phase plasma from the initial episode of SAB were higher in R-SAB than in matched S-SAB controls (P = .0053, false discovery rate < 0.10). CONCLUSION: This study identified several risk factors for R-SAB. The largest risk for R-SAB is among black hemodialysis patients. Higher RANTES levels in R-SAB compared to matched controls warrants further study.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Choi SH, Dagher M, Ruffin F, et al. Risk Factors for Recurrent Staphylococcus aureus Bacteremia. Clin Infect Dis. 2021. PMID: 32564065. doi:10.1093/cid/ciaa801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。